EDGAR Filing Documents for 0001140361-23-007830

Form DEFM14A - Definitive proxy statement relating to merger or acquisition:

SEC Accession No. 0001140361-23-007830

Filing Date

2023-02-21

Accepted

2023-02-21 16:05:32

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFM14A	ny20007218x2_defm14a.htm	DEFM14A	651812
2		ny20007218x2_pc01.jpg	GRAPHIC	625786
3		ny20007218x2_pc02.jpg	GRAPHIC	582032
	Complete submission text file	0001140361-23-007830.txt		2315886

Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036

Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891

Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: DEFM14A | Act: 34 | File No.: 001-37418 | Film No.: 23648060
SIC: 2834 Pharmaceutical Preparations